Cargando…
Downregulation of the Vitamin D Receptor Regulated Gene Set in the Hippocampus After MDMA Treatment
The active ingredient of ecstasy, ±3,4-methylenedioxymethamphetamine (MDMA), in addition to its initial reinforcing effects, induces selective and non-selective brain damage. Evidences suggest that the hippocampus (HC), a central region for cognition, may be especially vulnerable to impairments on t...
Autores principales: | Petschner, Peter, Balogh, Noemi, Adori, Csaba, Tamasi, Viola, Kumar, Sahel, Juhasz, Gabriella, Bagdy, Gyorgy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287013/ https://www.ncbi.nlm.nih.gov/pubmed/30559663 http://dx.doi.org/10.3389/fphar.2018.01373 |
Ejemplares similares
-
Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats
por: Petschner, Peter, et al.
Publicado: (2013) -
Retraction Note to: Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats
por: Petschner, Peter, et al.
Publicado: (2016) -
Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats
por: Petschner, Peter, et al.
Publicado: (2018) -
Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes
por: Tamási, Viola, et al.
Publicado: (2014) -
A single neurotoxic dose of MDMA decreases BDNF expression in the frontoparietal cortex but not in the hippocampus
por: Vas, Szilvia, et al.
Publicado: (2009)